Nav: Home

Study examines use, outcomes of valve replacement procedure performed for off-label indications

June 21, 2017

Approximately 1 in 10 transcatheter aortic valve replacement (TAVR) procedures in the U.S. were for an off-label indication, with similar 1-year mortality rates compared to on-label use, suggesting that TAVR may be a possible procedure option for certain patients requiring a heart valve replacement, according to a study published by JAMA Cardiology.

Transcatheter aortic valve replacement was approved by the U.S. Food and Drug Administration for severe aortic stenosis (narrowing of an artery) in patients who cannot undergo surgery and for patients at high operative risk.

Transcatheter aortic valve replacement is not currently recommended owing to limited proof of efficacy for a number of indications, including low surgical risk for conventional surgical aortic valve replacement (AVR) and moderate aortic stenosis; its use in such patients would be considered off-label. Use of TAVR for off-label indications has not been previously reported.

The authors note that off-label use implies that a therapy has not been studied in certain populations or for certain indications. It does not necessarily imply that therapy is inappropriate or ineffective for these patients.

Ravi S. Hira, M.D., of the University of Washington, Seattle, and colleagues examined patterns and adverse outcomes of off-label use of TAVR in U.S. clinical practice. The study included 23,847 patients from 328 sites performing TAVR between November 2011 and September 2014. Off-label TAVR was defined as TAVR in patients with the following conditions: known bicuspid valve, moderate aortic stenosis, severe mitral regurgitation, severe aortic regurgitation, or subaortic stenosis. Data were linked with the Centers for Medicare & Medicaid Services for 15,397 patients to evaluate 30-day and 1-year outcomes.

Among the patients in the study, off-label TAVR was used in 9.5 percent. Adjusted 30-day mortality was higher in the off-label group, while adjusted 1-year mortality was similar in the two groups. The median rate of off-label TAVR use per hospital was 6.8 percent.

"These results reinforce the continued need for additional research on the safety and efficacy of TAVR in specific patient cohorts with off-label indications for whom surgical AVR would be considered high risk or a prohibitive risk," the authors write.
-end-
Several limitations of the study are noted in the article.

For more details and to read the full study, please visit the For The Media website.

(doi:10.1001/jamacardio.2017.1685)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Related material: The editorials, "Off-Label Use of High-Risk Cardiovascular Devices," by Karen E. Joynt, M.D., M.P.H., and Daniel B. Kramer, M.D., M.P.H., of Brigham and Women's Hospital and the Harvard T.H. Chan School of Public Health, Boston; and "Evaluating Evolving Technologies in a Time of Rapid Change," by Robert M. Califf, M.D., of the Duke University School of Medicine, Durham, N.C., also are available at the For The Media website.

Related Audio Material: An author audio interview is available for preview on the For The Media website. The podcast will be live when the embargo lifts here: http://sites.jamanetwork.com/audio/

To place an electronic embedded link to this study in your story: Link will be live at the embargo time: http://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2017.1685

The JAMA Network Journals

Related Heart Valve Replacement Articles:

Risk of heart valve infections rising in hospitals
People with heart disease or defective or artificial heart valves are at increased risk of developing a potentially deadly valve infection.
Bioengineers explore cardiac tissue remodeling after aortic valve replacement procedures
Researchers have developed biomaterial-based 'mimics' of heart tissues to measure patients' responses to an aortic valve replacement procedure, offering new insight into the ways that cardiac tissue re-shapes itself post-surgery.
Paper trail leads to heart valve discoveries
Rice University bioengineers are studying heart disease with paper-based structures that mimic the layered nature of aortic valves, the tough, flexible tissues that keep blood flowing in one direction only.
Heart valve procedure safe for patients with common heart defect
A new analysis conducted by investigators at the Cedars-Sinai Smidt Heart Institute shows for the first time that patients with a common heart defect who undergo catheter-based valve replacement procedures have the same survival and complication rates as patients without the defect who undergo the same procedure.
New research addresses incidence of atrial fibrillation after aortic valve replacement
UAB investigators have outlined the incidence and implications of atrial fibrillation after transcatheter aortic valve implantation and surgical aortic valve replacement.
More Heart Valve Replacement News and Heart Valve Replacement Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...